您的位置:首页 > 推荐期刊 > 期刊详情
推荐期刊
Current signal transduction therapy
分享到:

影响因子:0.452

ISSN:1574-3624

出版社:Bentham Science Publishers

出版地:Sharjah, U.A.E

出版国家:United Arab Emirates

刊期:不规则

创刊时间:2006

语种:英文

审稿周期:12周,或约稿

中科院分区:4

投稿命中率:命中率约30.90%容易

国外数据收录:IMIM

中国收录文章数:0

5年影响因子:0.425

研究领域:信号转导

官方链接:http://www.ingentaconnect.com/content/ben/cst

投稿须知:http://www.ingentaconnect.com/content/ben/cst

期刊介绍:

In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The aim of this journal is to publish timely in-depth reviews as well as original papers in the field of signal transduction therapy. Thematic issues will also be published to cover selected areas of signal transduction therapy. Coverage of the field will include genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

同领域期刊名称 影响因子

维普投稿-SCI专栏论文服务由广州品恒信息科技有限公司独立运营并承担相应的责任与义务

友情链接:维普网 | 维普投稿平台 | 维普论文检测 | 维普论文选题